INDIAN
BENCHMARK open flat with a slight negative bias. Investors booked profits in
oil and financial shares. Jubilant Life Sciences subsidiary will receive over
Rs 860 crore funding from IFC, a member of the World Bank Group, to strengthen
its generic drug manufacturing facilities.
FURTHER, GAIL India
reported a 57% jump in its fourth-quarter net profit on the back of better
petrochemical and LPG prices and drop in subsidy outgo.Wockhardt reported
nearly 78% drop in consolidated net profit at Rs 74.45 crore for the quarter
ended March 2014 mainly due to regulatory issues with US and UK health
regulators.
Trend in FII flows: The FIIs
were net sellers of Rs 84cr in the cash segment on Monday while the
domestic institutional investors (DIIs) were net sellers
of Rs. 208cr, as per the provisional figures released by the NSE.
0 comments:
Post a Comment